AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Abbott Laboratories is set to release its Q4 earnings, with its stock trading at around $118 per share. The company has a HOLD rating due to its premium valuation and lack of clear growth prospects.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet